<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04486599</url>
  </required_header>
  <id_info>
    <org_study_id>RC31/19/0516</org_study_id>
    <nct_id>NCT04486599</nct_id>
  </id_info>
  <brief_title>Electromagnetic Navigation During Ultrasound Guided Foam Sclerotherapy for Venous Malformations</brief_title>
  <acronym>SCLERONAV</acronym>
  <official_title>Feasibility of Electromagnetic Navigation During Ultrasound Guided Foam Sclerotherapy for the Treatment of Venous Malformations.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Toulouse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Toulouse</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the feasibility of assisted electromagnetic navigation&#xD;
      in percutaneous echo-guided sclerotherapy of slow-flow vascular malformations. Feasibility&#xD;
      will be defined in terms of the percentage of patients for whom the procedure is successful.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary interventional treatment of low flow vascular anomalies includes ultrasound guided&#xD;
      foam sclerotherapy. Each procedure involves a percutaneous needle insertion. However,&#xD;
      procedures remain complicated to obtain the right trajectory in order to inject the foam at&#xD;
      the center of the abnormality. Electromagnetic navigation system tracks the operator's&#xD;
      needle, meaning the position and progression of the needle is visualized in 3D real time on&#xD;
      the ultrasound probe interface.&#xD;
&#xD;
      The present trial evaluate the feasibility of the electromagnetic navigation system during&#xD;
      the needle insertion and the improvement of needle placement accuracy.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 15, 2020</start_date>
  <completion_date type="Anticipated">July 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of patients for whom the procedure is successful</measure>
    <time_frame>day 1</time_frame>
    <description>Success of procedure a.e. obtention of venous flow at the extremity of the needle permitting the realization of the foam sclerotherapy treatment.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Estimate the number of punctures required to achieve catheterization of the malformation.</measure>
    <time_frame>day 1</time_frame>
    <description>Number of percutaneous punctures needed to obtain vascular backflow.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estimate the time to complete catheterization of the malformation</measure>
    <time_frame>day 1</time_frame>
    <description>Duration of the procedure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estimate the undesirable effects associated with assisted electromagnetic navigation.</measure>
    <time_frame>day 1</time_frame>
    <description>Adverse effects of Electro-Magnetic Navigation.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Venous Malformation</condition>
  <arm_group>
    <arm_group_label>Electromagnetic Navigation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patient have to low Flow Vascular Abnormality diagnosed by Duplex Ultrasound and MRI. Decision of Ultrasound Guided Percutaneous Foam Sclerotherapy taken in multidisciplinary staff meeting</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Electromagnetic Navigation</intervention_name>
    <description>The echo-guided sclerotherapy procedure, assisted by electromagnetic navigation, will be carried out in a clean room during the day hospitalisation and followed by a control Echo-Doppler carried out 2 hours after the procedure.</description>
    <arm_group_label>Electromagnetic Navigation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Low Flow Vascular Abnormality diagnosed by Duplex Ultrasound and MRI&#xD;
&#xD;
          -  Decision of Ultrasound Guided Percutaneous Foam Sclerotherapy taken in&#xD;
             multidisciplinary staff meeting&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients with pacemakers or internal defibrillator&#xD;
&#xD;
          -  patients with ferromagnetic implanted material&#xD;
&#xD;
          -  patients who are wards of court or under guardianship&#xD;
&#xD;
          -  patients deprived of freedom by judicial or administrative decision&#xD;
&#xD;
          -  patients under legal protection&#xD;
&#xD;
          -  pregnant women&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wassim Mokaddem, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Toulouse</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wassim Mokaddem, MD</last_name>
    <phone>33-561323035</phone>
    <email>mokaddem.w@chu-toulouse.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Toulouse</city>
        <state>Occitanie</state>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wassim MOKADDEM</last_name>
      <phone>05 61 32 30 35</phone>
      <phone_ext>+33</phone_ext>
      <email>mokaddem.w@chu-toulouse.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>July 9, 2020</study_first_submitted>
  <study_first_submitted_qc>July 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 24, 2020</study_first_posted>
  <last_update_submitted>November 9, 2020</last_update_submitted>
  <last_update_submitted_qc>November 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Foam Sclerotherapy</keyword>
  <keyword>Ultrasound</keyword>
  <keyword>Electromagnetic Navigation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Congenital Abnormalities</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

